What kinds of treatment did you receive for thrombocytopenia?
Share your story with others:
MedicineNet appreciates your comment. Your comment may be displayed on the site and will always be published anonymously.
How is thrombocytopenia treated?
The treatment of thrombocytopenia is largely dependent upon the cause and the severity of the condition.
Some situations may require specific or emergent treatments, whereas, others
need only be managed by occasional blood draws and monitoring of the platelet levels.
In auto-immune thrombocytopenia or ITP, steroids can be used to suppress the immune system in order to impair the
destruction of platelets. In more severe cases, intravenous immunoglobulins (IVIG) or
monoclonal antibodies may also be given to alter the immune process. In refractory cases, splenectomy (removal of the spleen) may be necessary.
If a drug is thought to be the cause of low platelet count, then it may be discontinued by the supervising physician. In patients with HIT, it is very important to remove and
limit the future use of any heparin products, including low molecular weight heparin (like Lovenox), immediately to prevent further immune response against the platelets.
If TTP or HUS is diagnosed, the treatment may include plasma exchange,
plasmapheresis, or eculizumab. In cases with severe kidney failure, dialysis may be necessary.
In general, platelet transfusion is not necessary, unless an individual with low platelets (less than 50,000) has an active bleeding or hemorrhage, or needs a surgery or other invasive procedures.
Frequently, a platelet transfusion may be recommended without any bleeding if
the count is less than 10,000.
In suspected cases of HIT or TTP, transfusion of platelets may not be
recommended because the new platelets could potentially make the condition worse and more prolonged.